cycloheximide has been researched along with epirubicin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiba, H; Furusawa, S; Nakano, S; Sasaki, K; Takayanagi, M; Takayanagi, Y; Wada, M | 1 |
| Cabrera, E; Freire, R; Gomes, AR; Gong, C; Karunarathna, U; Khongkow, P; Khoo, US; Kongsema, M; Lam, EW; Man, EP; Medema, RH; Tsang, JW; Zona, S | 1 |
2 other study(ies) available for cycloheximide and epirubicin
| Article | Year |
|---|---|
Augmentation of epirubicin cytotoxicity by cycloheximide.
Topics: Animals; Antibiotics, Antineoplastic; Cell Division; Cycloheximide; DNA, Neoplasm; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Epirubicin; Leukemia P388; Mice; Protein Synthesis Inhibitors; Tetrazolium Salts; Thiazoles | 1996 |
OTUB1 inhibits the ubiquitination and degradation of FOXM1 in breast cancer and epirubicin resistance.
Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cycloheximide; Cysteine Endopeptidases; Deubiquitinating Enzymes; DNA Damage; DNA Repair; Drug Resistance, Neoplasm; Epirubicin; Female; Forkhead Box Protein M1; Forkhead Transcription Factors; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Protein Synthesis Inhibitors; RNA Interference; RNA, Small Interfering; Ubiquitination | 2016 |